Singular Genomics Systems Inc (NASDAQ: OMIC) is -10.31% lower on its value in year-to-date trading and has touched a low of $5.34 and a high of $19.80 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The OMIC stock was last observed hovering at around $5.65 in the last trading session, with the day’s gains setting it 6.73%.
Currently trading at $12.38, the stock is 93.32% and 69.52% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.84 million and changing 119.12% at the moment leaves the stock 5.14% off its SMA200. OMIC registered -5.13% loss for a year compared to 6-month loss of -22.17%.
The stock witnessed a 69.47% gain in the last 1 month and extending the period to 3 months gives it a 18.58%, and is 110.10% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 14.95% over the week and 10.12% over the month.
Singular Genomics Systems Inc (OMIC) has around 265 employees, a market worth around $30.95M and $2.72M in sales. Profit margin for the company is -3375.72%. Distance from 52-week low is 131.84% and -37.47% from its 52-week high. The company has generated returns on investments over the last 12 months (-45.39%).
The EPS is expected to grow by 10.79% this year.
Singular Genomics Systems Inc (OMIC) Top Institutional Holders
37.0 institutions hold shares in Singular Genomics Systems Inc (OMIC), with institutional investors hold 47.89% of the company’s shares. The shares outstanding are 2.46M, and float is at 1.49M with Short Float at 0.77%. Institutions hold 41.23% of the Float.
#####
Singular Genomics Systems Inc (OMIC) Insider Activity
The most recent transaction is an insider purchase by Spaventa Andrew, the company’s Chief Executive Officer. SEC filings show that Spaventa Andrew bought 75,000 shares of the company’s common stock on Nov 17 ’23 at a price of $0.42 per share for a total of $31755.0. Following the purchase, the insider now owns 4.06 million shares.
Singular Genomics Systems Inc disclosed in a document filed with the SEC on Nov 16 ’23 that Spaventa Andrew (Chief Executive Officer) bought a total of 43,468 shares of the company’s common stock. The trade occurred on Nov 16 ’23 and was made at $0.41 per share for $17857.0. Following the transaction, the insider now directly holds 3.99 million shares of the OMIC stock.
Still, SEC filings show that on Nov 16 ’23, Glezer Eli N. (Chief Scientific Officer) acquired 200,000 shares at an average price of $0.43 for $85640.0. The insider now directly holds 4,570,000 shares of Singular Genomics Systems Inc (OMIC).
